LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 325 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $703 | +234.8% | 24,327 | +735.7% | 0.00% | +100.0% |
Q2 2023 | $210 | -1.9% | 2,911 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $214 | +10.3% | 2,911 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $194 | -99.9% | 2,911 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $251,000 | -3.5% | 2,911 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $260,000 | -20.5% | 2,911 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $327,000 | -38.1% | 2,911 | -14.9% | 0.00% | -50.0% |
Q4 2021 | $528,000 | +10.7% | 3,421 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $477,000 | +6.2% | 3,421 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $449,000 | -14.0% | 3,421 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $522,000 | +53.5% | 3,421 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $340,000 | +4.3% | 3,421 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $326,000 | -14.9% | 3,421 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $383,000 | +38.8% | 3,421 | -10.0% | 0.00% | 0.0% |
Q1 2020 | $276,000 | -30.3% | 3,801 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $396,000 | +4.8% | 3,801 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $378,000 | -12.9% | 3,801 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $434,000 | -17.3% | 3,801 | -9.1% | 0.00% | 0.0% |
Q1 2019 | $525,000 | -7.4% | 4,180 | 0.0% | 0.00% | -25.0% |
Q4 2018 | $567,000 | -50.6% | 4,180 | 0.0% | 0.00% | -42.9% |
Q3 2018 | $1,147,000 | +32.4% | 4,180 | 0.0% | 0.01% | +16.7% |
Q2 2018 | $866,000 | +25.5% | 4,180 | 0.0% | 0.01% | +20.0% |
Q1 2018 | $690,000 | +4.4% | 4,180 | -13.5% | 0.01% | +25.0% |
Q4 2017 | $661,000 | +0.5% | 4,830 | 0.0% | 0.00% | -20.0% |
Q3 2017 | $658,000 | +12.3% | 4,830 | 0.0% | 0.01% | +25.0% |
Q2 2017 | $586,000 | +14.7% | 4,830 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $511,000 | +2.4% | 4,830 | -1.7% | 0.00% | 0.0% |
Q4 2016 | $499,000 | -0.6% | 4,914 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $502,000 | -19.3% | 4,914 | -5.8% | 0.00% | -20.0% |
Q2 2016 | $622,000 | -7.3% | 5,216 | -16.8% | 0.01% | -16.7% |
Q1 2016 | $671,000 | -1.3% | 6,270 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $680,000 | +26.6% | 6,270 | 0.0% | 0.01% | +20.0% |
Q3 2015 | $537,000 | -16.9% | 6,270 | -2.0% | 0.01% | 0.0% |
Q2 2015 | $646,000 | -1.1% | 6,400 | -24.5% | 0.01% | 0.0% |
Q1 2015 | $653,000 | +44.8% | 8,472 | 0.0% | 0.01% | +25.0% |
Q4 2014 | $451,000 | +13.3% | 8,472 | 0.0% | 0.00% | +33.3% |
Q3 2014 | $398,000 | -24.6% | 8,472 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $528,000 | -7.4% | 8,472 | 0.0% | 0.00% | -20.0% |
Q1 2014 | $570,000 | +27.8% | 8,472 | 0.0% | 0.01% | +25.0% |
Q4 2013 | $446,000 | +21.5% | 8,472 | 0.0% | 0.00% | +33.3% |
Q3 2013 | $367,000 | +15.8% | 8,472 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $317,000 | – | 8,472 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |